FinnHubMedicenna Therapeutics Corp. Reports Earnings Results for the Full Year Ended March 31, 20255 days ago
FinnHubMedicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting3 months ago
FinnHubMedicenna Reports MDNA11’s Compelling Anti-Cancer Activity is Associated with Significant Expansion of ‘Stem-Like’ Cancer Fighting Immune Cells at the Inaugural AACR-Immuno-Oncology Conference and Provides ABILITY-1 Study Update4 months ago
CashuMedicenna Therapeutics Corp. Outlines Strategic Focus Amid Financial and Development Challenges3 days ago
CashuMedicenna Therapeutics Corp. Reports Financial Gains and Advances in Therapeutic Platforms5 days ago